Phytoceuticals: the new ‘physic garden’ for asthma and chronic obstructive pulmonary disease

References

• Hill AW. The history and functions of botanic gardens. Ann. Missouri Bot. Garden2, 185–240 (1915).
   Google Scholar
• Leonard P, Sur S. Asthma: future directions. Med. Clin. North Am.86, 1131–1156 (2002).
   Google Scholar
• World Health Organization. WHO factsheet 206: bronchial asthma. World Health Organization (2000).
   Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy59, 469–478 (2004).
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet349, 1436–1442 (1997).
   PubMed Web of Science ®Google Scholar
• Petty TL. COPD in perspective. Chest121, S116–S120 (2002).
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF. Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease. Expert Opin. Pharmacother.1, 1007–1020 (2000).
   PubMedGoogle Scholar
• Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med.161, 381–390 (2000).
   PubMed Web of Science ®Google Scholar
• Willemse BWM, ten Hacken NHT, Rutgers B, Lesman-Leegte IGAT, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur. Respir. J.26, 835–845 (2005).
   PubMed Web of Science ®Google Scholar
• Kay AB. Allergy and allergic diseases. First of two parts. N. Engl. J. Med.344, 30–37 (2001).
   PubMed Web of Science ®Google Scholar
• Fahy JV, Corry DB, Boushey HA. Airway inflammation and remodeling in asthma. Curr. Opin. Pulm. Med.6, 15–20 (2000).
   PubMedGoogle Scholar
• Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc.24, 79–83 (2003).
   PubMed Web of Science ®Google Scholar
• Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol.111, 215–225 (2003).
   PubMed Web of Science ®Google Scholar
• Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax54, 1061–1069 (1999).
   PubMed Web of Science ®Google Scholar
• Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J. Allergy Clin. Immunol.112, 819–827 (2003).
   PubMed Web of Science ®Google Scholar
• Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol.533, 240–252 (2006).
   PubMed Web of Science ®Google Scholar
• Nightingale JA, Maggs R, Cullinan P et al. Airway inflammation after controlled exposure to diesel exhaust particulates. Am. J. Respir. Crit. Care Med.162, 161–166 (2000).
   PubMed Web of Science ®Google Scholar
• Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs63, 1973–1998 (2003).
   PubMed Web of Science ®Google Scholar
• Tattersfield AE. Current issues with β2-adrenoceptor agonists: historical background. Clin. Rev. Allergy Immunol.31, 107–118 (2006).
   PubMed Web of Science ®Google Scholar
• Broadley KJ. β-adrenoceptor responses of the airways: for better or worse? Eur. J. Pharmacol.533, 15–27 (2006).
   PubMed Web of Science ®Google Scholar
• McDonald NJ, Bara AI. Anticholinergic therapy for chronic asthma in children over two years of age. Cochrane Database Syst. Rev.CD003535 (2003).
   Google Scholar
• Appleton S, Poole P, Smith B, Veale A, Lasserson TJ, Chan MM. Long-acting β2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane. Database. Syst. Rev.3, CD001104 (2006).
   Google Scholar
• Salpeter SR, Buckley NS. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: β-agonist use compared with anticholinergics and inhaled corticosteroids. Clin. Rev. Allergy Immunol.31, 219–230 (2006).
   PubMed Web of Science ®Google Scholar
• Cazzola M, Matera MG, Donner CF. Inhaled β2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs65, 1595–1610 (2005).
   PubMed Web of Science ®Google Scholar
• Barr RG, Bourbeau J, Camargo CA, Ram FSF. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax61, 854–862 (2006).
   PubMed Web of Science ®Google Scholar
• Whitehouse MW. Drugs to treat inflammation: a historical introduction. Curr. Med. Chem.12, 2931–2942 (2005).
   PubMed Web of Science ®Google Scholar
• Heaney LG, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet365, 974–976 (2005).
   PubMed Web of Science ®Google Scholar
• Burge PS. EUROSCOP, ISOLDE and the Copenhagen City Lung Study. Thorax54, 287–288 (1999).
   PubMed Web of Science ®Google Scholar
• Walters JA, Walters EH, Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.CD005374 (2005).
   Google Scholar
• Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD2, 445–455 (2005).
   PubMedGoogle Scholar
• Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet363, 731–733 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson M. Interactions between corticosteroids and β2-agonists in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc.1, 200–206 (2004).
   PubMedGoogle Scholar
• Akazawa M, Stempel DA. Single-inhaler combination therapy for asthma: a review of cost effectiveness. Pharmacoeconomics24, 971–988 (2006).
   PubMed Web of Science ®Google Scholar
• Markham A, Jarvis B. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Drugs60, 1207–1233 (2000).
   PubMed Web of Science ®Google Scholar
• Tal A, Simon G, Vermeulen JH et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr. Pulmonol.34, 342–350 (2002).
   PubMed Web of Science ®Google Scholar
• Cockcroft DW. Pharmacologic therapy for asthma: overview and historical perspective. J. Clin. Pharmacol.39, 216–222 (1999).
   PubMedGoogle Scholar
• Angsten JM. Use of complementary and alternative medicine in the treatment of asthma. Adolesc. Med.11, 535–546 (2000).
   Google Scholar
• AnonPetasites hybridus. Altern. Med. Rev.6, 207–209 (2001).
   Google Scholar
• Kalin P. [The common butterbur (Petasites hybridus) – portrait of a medicinal herb]. Forsch. Komplementarmed. Klass. Naturheilkd.10(Suppl. 1), 41–44 (2003).
   PubMedGoogle Scholar
• Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology63, 2240–2244 (2004).
   PubMed Web of Science ®Google Scholar
• Thomet OA, Wiesmann UN, Schapowal A, Bizer C, Simon HU. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem. Pharmacol.61, 1041–1047 (2001).
   PubMed Web of Science ®Google Scholar
• Thomet OA, Wiesmann UN, Blaser K, Simon HU. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. Clin. Exp. Allergy31, 1310–1320 (2001).
   Google Scholar
• Ko WC, Lei CB, Lin YL, Chen CF. Relaxant effects of petasins in isolated guinea pig trachea and their structure–activity relationships. Planta Med.66, 650–652 (2000).
   Google Scholar
• Ko WC, Lei CB, Lin YL, Chen CF. Mechanisms of relaxant action of S-petasin and S-isopetasin, sesquiterpenes of Petasites formosanus, in isolated guinea pig trachea. Planta Med.67, 224–229 (2001).
   Google Scholar
• Wang GJ, Liao JF, Hintz KK et al. Calcium-antagonizing activity of S-petasin, a hypotensive sesquiterpene from Petasites formosanus, on inotropic and chronotropic responses in isolated rat atria and cardiac myocytes. Naunyn Schmiedebergs Arch. Pharmacol.369, 322–329 (2004).
   Google Scholar
• Hirota K, Hashiba E, Yoshioka H, Kabara S, Matsuki A. Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation. Br. J. Anaesth.90, 671–675 (2003).
   PubMed Web of Science ®Google Scholar
• Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. Br. Med. J.324, 144–146 (2002).
   PubMed Web of Science ®Google Scholar
• Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, Lipworth BJ. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin. Exp. Allergy33, 882–886 (2003).
   PubMed Web of Science ®Google Scholar
• Gray RD, Haggart K, Lee DK, Cull S, Lipworth BJ. Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation. Ann. Allergy Asthma Immunol.93, 56–60 (2004).
   PubMed Web of Science ®Google Scholar
• Kaufeler R, Polasek W, Brattstrom A, Koetter U. Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study. Adv. Ther.23, 373–384 (2006).
   Google Scholar
• Lee DK, Haggart K, Robb FM, Lipworth BJ. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin. Exp. Allergy34, 110–114 (2004).
   PubMed Web of Science ®Google Scholar
• Ziolo G, Samochowiec L. Study on clinical properties and mechanisms of action of Petasites in bronchial asthma and chronic obstructive bronchitis. Pharm. Acta Helv.72, 378–380 (1998).
   Google Scholar
• Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache43, 76–78 (2003).
   PubMed Web of Science ®Google Scholar
• Grieve M. A Modern Herbal. (1971).
   Google Scholar
• Demirci B, Goppel M, Demirci F, Franz G. HPLC profiling and quantification of active principles in leaves of Hedera helix L. Pharmazie59, 770–774 (2004).
   PubMed Web of Science ®Google Scholar
• Julien J, Gasquet M, Maillard C, Balansard G, Timon-David P. Extracts of the ivy plant, Hedera helix, and their anthelminthic activity on liver flukes. Planta Med.51, 205–208 (1985).
   Google Scholar
• Elias R, Diaz Lanza AM, Vidal-Ollivier E, Balansard G, Faure R, Babadjamian A. Triterpenoid saponins from the leaves of Hedera helix. J. Natural Products54, 98–103 (1991).
   Google Scholar
• Timon-David P, Julien J, Gasquet M, Balansard G, Bernard P. [Research of antifungal activity from several active principle extracts from climbing-ivy: Hedera helix L (author’s transl)]. Ann. Pharm. Fr.38, 545–552 (1980).
   PubMed Web of Science ®Google Scholar
• Hostettmann K. Saponins with molluscicidal activity from Hedera helix. Helvetica Chimica Acta63, 606–609 (1980).
   Web of Science ®Google Scholar
• Suleyman H, Mshvildadze V, Gepdiremen A, Elias R. Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats. Phytomedicine10, 370–374 (2003).
   PubMed Web of Science ®Google Scholar
• Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch. Pharm. (Weinheim)328, 720–724 (1995).
   PubMed Web of Science ®Google Scholar
• Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med.63, 125–129 (1997).
   PubMed Web of Science ®Google Scholar
• Billington T, Pharmawati M, Gehring CA. Isolation and immunoaffinity purification of biologically active plant natriuretic peptide. Biochem. Biophys. Res. Commun.235, 722–725 (1997).
   Google Scholar
• Mikawa K, Kume H, Takagi K. Effects of atrial natriuretic peptide and 8-brom cyclic guanosine monophosphate on human tracheal smooth muscle. Arzneimittelforschung48, 914–918 (1998).
   Google Scholar
• Hofmann D, Hecker M, Volp A. Efficacy of dry extract of ivy leaves in children with bronchial asthma – a review of randomized controlled trials. Phytomedicine10, 213–220 (2003).
   PubMed Web of Science ®Google Scholar
• Hecker M, Runkel F, Voelp A. [Treatment of chronic bronchitis with ivy leaf special extract – multicenter post-marketing surveillance study in 1,350 patients]. Forsch. Komplementarmed. Klass. Naturheilkd.9, 77–84 (2002).
   Google Scholar
• Buechi S, Vogelin R, von Eiff MM, Ramos M, Melzer J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch. Komplementarmed. Klass. Naturheilkd.12, 328–332 (2005).
   Google Scholar
• Fazio S, Pouso J, Dolinsky D et al. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: A prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine (2006) (Epub ahead of print).
   Google Scholar
• Mahran GH, Hilal SH, el Alfy TS. The isolation and characterisation of emetine alkaloid from Hedera helix. Planta Med.27, 127–132 (1975).
   Google Scholar
• Hausen BM, Brohan J, Konig WA, Faasch H, Hahn H, Bruhn G. Allergic and irritant contact dermatitis from falcarinol and didehydrofalcarinol in common ivy (Hedera helix L.). Contact Dermatitis17, 1–9 (1987).
   PubMed Web of Science ®Google Scholar
• Yesudian PD, Franks A. Contact dermatitis from Hedera helix in a husband and wife. Contact Dermatitis46, 125–126 (2002).
   Google Scholar
• Keen CL. Chocolate: food as medicine/medicine as food. J. Am. Coll. Nutr.20, S436–S439 (2001).
   PubMed Web of Science ®Google Scholar
• Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J. Agric. Food Chem.51, 7292–7295 (2003).
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol.13, 41–49 (2002).
   PubMed Web of Science ®Google Scholar
• Lotito SB, Actis-Goretta L, Renart ML et al. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem. Biophys. Res. Comm.276, 945–951 (2000).
   PubMed Web of Science ®Google Scholar
• Selmi C, Mao TK, Keen CL, Schmitz HH, Eric GM. The anti-inflammatory properties of cocoa flavanols. J. Cardiovasc. Pharmacol.47(Suppl. 2), S163–S171 (2006).
   PubMed Web of Science ®Google Scholar
• Lotito SB, Fraga CG. Catechins delay lipid oxidation and α-tocopherol and β-carotene depletion following ascorbate depletion in human plasma. Proc. Soc. Exp. Biol. Med.225, 32–38 (2000).
   PubMed Web of Science ®Google Scholar
• Ono K, Takahashi T, Kamei M et al. Effects of an aqueous extract of cocoa on nitric oxide production of macrophages activated by lipopolysaccharide and interferon-γ. Nutrition19, 681–685 (2003).
   PubMed Web of Science ®Google Scholar
• Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-κB activation at multiple steps in Jurkat T cells. FASEB J.18, 167–169 (2004).
   PubMed Web of Science ®Google Scholar
• Mao T, Van de Water J, Keen CL, Schmitz HH, Gershwin ME. Cocoa procyanidins and human cytokine transcription and secretion. J. Nutr.130, S2093–S2209 (2000).
   PubMed Web of Science ®Google Scholar
• Mao TK, van de WJ, Keen CL, Schmitz HH, Gershwin ME. Modulation of TNF-α secretion in peripheral blood mononuclear cells by cocoa flavanols and procyanidins. Dev. Immunol.9, 135–141 (2002).
   PubMedGoogle Scholar
• Arteel GE, Schroeder P, Sies H. Reactions of peroxynitrite with cocoa procyanidin oligomers. J. Nutr.130, S2100–S22104 (2000).
   PubMed Web of Science ®Google Scholar
• Usmani OS, Belvisi MG, Patel HJ et al. Theobromine inhibits sensory nerve activation and cough. FASEB J.19, 231–233 (2004).
   Google Scholar
• Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol.16, 457–499 (1998).
   PubMedGoogle Scholar
• Brown MA, Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol.17, 1–32 (1997).
   PubMed Web of Science ®Google Scholar
• Wang JF, Schramm DD, Holt RR et al. A dose–response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr.130, S2115–S2119 (2000).
   PubMed Web of Science ®Google Scholar
• Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG. Epicatechin in Human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J. Nutr.130, S2109–S2214 (2000).
   PubMed Web of Science ®Google Scholar
• Mumford GK, Benowitz NL, Evans SM et al. Absorption rate of methylxanthines following capsules, cola and chocolate. Eur. J. Clin. Pharmacol.51, 319–325 (1996).
   PubMed Web of Science ®Google Scholar
• Simons FE, Becker AB, Simons KJ, Gillespie CA. The bronchodilator effect and pharmacokinetics of theobromine in young patients with asthma. J. Allergy Clin. Immunol.76, 703–707 (1985).
   Google Scholar
• Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J. Altern. Complement. Med.11, 521–528 (2005).
   PubMed Web of Science ®Google Scholar
• Sato T, Miyata G. The nutraceutical benefit, part I: green tea. Nutrition16, 315–317 (2000).
   PubMed Web of Science ®Google Scholar
• Khokhar S, Venema D, Hollman PC, Dekker M, Jongen W. A RP-HPLC method for the determination of tea catechins. Cancer Lett.114, 171–172 (1997).
   PubMed Web of Science ®Google Scholar
• Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys.322, 339–346 (1995).
   PubMed Web of Science ®Google Scholar
• Dufresne CJ, Farnworth ER. A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem.12, 404–421 (2001).
   PubMed Web of Science ®Google Scholar
• Lin YL Lin JK. (-)-epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol.52, 465–472 (1997).
   PubMed Web of Science ®Google Scholar
• Syed DN, Afaq F, Kweon MH et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells. Oncogene26, 673–682 (2007).
   PubMed Web of Science ®Google Scholar
• Kim IB, Kim DY, Lee SJ et al. Inhibition of IL-8 production by green tea polyphenols in human nasal fibroblasts and a549 epithelial cells. Biol. Pharm. Bull.29, 1120–1125 (2006).
   PubMed Web of Science ®Google Scholar
• Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG, Wong HR. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IκB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation26, 233–241 (2002).
   PubMed Web of Science ®Google Scholar
• Wheeler DS, Catravas JD, Odoms K, Denenberg A, Malhotra V, Wong HR. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1{β}-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J. Nutr.134, 1039–1044 (2004).
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Oura H, Nakagawa H, Sakanaka S, Kim M. Effects of a component of green tea on the proliferation of vascular smooth muscle cells. Biosci. Biotechnol. Biochem.59, 2134–2136 (1995).
   PubMed Web of Science ®Google Scholar
• Hofbauer R, Frass M, Gmeiner B, Handler S, Speiser W, Kapiotis S. The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells. Wien. Klin. Wochenschr.111, 278–282 (1999).
   PubMed Web of Science ®Google Scholar
• Alexis AF, Jones VA, Stiller MJ. Potential therapeutic applications of tea in dermatology. Int. J. Dermatol.38, 735–743 (1999).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Caso C, Rodriguez-Agudo D, Sanchez-Jimenez F, Medina MA. Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase. Cell Mol. Life Sci.60, 1760–1763 (2003).
   PubMed Web of Science ®Google Scholar
• Sartor L, Pezzato E, Garbisa S. (-)epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J. Leukoc. Biol.71, 73–79 (2002).
   PubMed Web of Science ®Google Scholar
• Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochimica Biophysica Acta1478, 51–60 (2000).
   PubMed Web of Science ®Google Scholar
• Dona M, Dell’Aica I, Calabrese F et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol.170, 4335–4341 (2003).
   PubMed Web of Science ®Google Scholar
• Kim SH, Park HJ, Lee CM et al. Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma. FEBS Lett.580, 1883–1890 (2006).
   PubMed Web of Science ®Google Scholar
• Bani D, Giannini L, Ciampa A et al. Epigallocatechin-3-gallate reduces allergen-induced asthma-like reaction in sensitized guinea pigs. J. Pharmacol. Exp. Ther.317, 1002–1011 (2006).
   PubMed Web of Science ®Google Scholar
• Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr.54, 87–92 (2000).
   PubMed Web of Science ®Google Scholar
• Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr.128, 2334–2340 (1998).
   PubMed Web of Science ®Google Scholar
• Shirai T, Reshad K, Yoshitomi A, Chida K, Nakamura H, Taniguchi M. Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Clin. Exp. Allergy33, 1252–1255 (2003).
   Web of Science ®Google Scholar
• Shirai T, Sato A, Chida K et al. Epigallocatechin gallate-induced histamine release in patients with green tea-induced asthma. Ann. Allergy Asthma Immunol.79, 65–69 (1997).
   Google Scholar
• Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr.81, S243–S255 (2005).
   PubMed Web of Science ®Google Scholar
• Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, Torronen AR. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J. Agric. Food Chem.47, 2274–2279 (1999).
   PubMed Web of Science ®Google Scholar
• Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr. J.3, 5 (2004).
   PubMed Web of Science ®Google Scholar
• Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr.81, S230–S242 (2005).
   PubMed Web of Science ®Google Scholar
• Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol.33, 1061–1080 (1995).
   PubMed Web of Science ®Google Scholar
• Chaabi M, Freund-Michel V, Frossard N, Randriantsoa A, Andriantsitohaina R, Lobstein A. Anti-proliferative effect of Euphorbia stenoclada in human airway smooth muscle cells in culture. J. Ethnopharmacol.109, 134–139 (2007).
   Google Scholar
• Paliyath G, Poovaiah BW. Identification of naturally occurring calmodulin inhibitors in plants and their effects on calcium- and calmodulin-promoted protein phosphorylation. Plant Cell Physiol.26, 201–209 (1985).
   PubMed Web of Science ®Google Scholar
• Nishino H, Naitoh E, Iwashima A, Umezawa K. Quercetin interacts with calmodulin, a calcium regulatory protein. Experientia40, 184–185 (1984).
   PubMedGoogle Scholar
• Nair MPN, Kandaswami C, Mahajan S et al. The flavonoid, quercetin, differentially regulates Th-1 (IFN[γ]) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim. Biophys. Acta1593, 29–36 (2002).
   PubMed Web of Science ®Google Scholar
• Kobuchi H, Roy S, Sen CK, Nguyen HG, Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol. Cell. Physiol.277, C403–C411 (1999).
   Web of Science ®Google Scholar
• Donnelly LE, Newton R, Kennedy GE et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol.287, L774–L783 (2004).
   PubMed Web of Science ®Google Scholar
• Kim HP, Mani I, Iversen L, Ziboh VA. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot. Essent. Fatty Acids58, 17–24 (1998).
   PubMed Web of Science ®Google Scholar
• Banerjee T, van der Vliet A, Ziboh VA. Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line. Prostaglandins Leukot. Essent. Fatty Acids66, 485–492 (2002).
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kim JS, Rubin BK. Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. Am. J. Physiol. Lung Cell. Mol. Physiol.292, L62–L67 (2007).
   PubMed Web of Science ®Google Scholar
• Zaslaver M, Offer S, Kerem Z et al. Natural compounds derived from foods modulate nitric oxide production and oxidative status in epithelial lung cells. J. Agric. Food Chem.53, 9934–9939 (2005).
   PubMed Web of Science ®Google Scholar
• Shen SC, Lee WR, Lin HY et al. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Eur. J. Pharmacol.446, 187–194 (2002).
   PubMed Web of Science ®Google Scholar
• Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J.351, 95–105 (2000).
   PubMed Web of Science ®Google Scholar
• Agullo G, Gamet-Payrastre L, Manenti S et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol.53, 1649–1657 (1997).
   PubMed Web of Science ®Google Scholar
• Huang Y-T, Hwang J-J, Lee P-P et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol.128, 999–1010 (1999).
   PubMed Web of Science ®Google Scholar
• Nanua S, Zick SM, Andrade JE et al. Quercetin blocks airway epithelial cell chemokine expression. Am. J. Respir. Cell Mol. Biol.35, 602–610 (2006).
   PubMed Web of Science ®Google Scholar
• Ko WC, Shih CM, Chen MC et al. Suppressive effects of 3-O-methylquercetin on ovalbumin-induced airway hyperresponsiveness. Planta Med.70, 1123–1127 (2004).
   PubMedGoogle Scholar
• Raju TAN, Lakshmi ANV, Anand T, Rao LV, Sharma G. Protective effects of quercetin during influenza virus-induced oxidative stress. Asia Pacific J. Clin. Nutr.9, 314–317 (2000).
   Google Scholar
• Kumar P, Sharma S, Khanna M, Raj HG. Effect of quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int. J. Exp. Pathol.84, 127–133 (2003).
   PubMed Web of Science ®Google Scholar
• Selloum L, Reichl S, Muller M, Sebihi L, Arnhold J. Effects of flavonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils. Arch. Biochem. Biophys.395, 49–56 (2001).
   PubMed Web of Science ®Google Scholar
• Erlund I, Kosonen T, Alfthan G et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol.56, 545–553 (2000).
   PubMed Web of Science ®Google Scholar
• Knekt P, Kumpulainen J, Jarvinen R et al. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr.76, 560–568 (2002).
   PubMed Web of Science ®Google Scholar
• Woods RK, Walters EH, Raven JM et al. Food and nutrient intakes and asthma risk in young adults. Am. J. Clin. Nutr.78, 414–421 (2003).
   PubMed Web of Science ®Google Scholar
• Shaheen SO, Sterne JAC, Thompson RL, Songhurst CE, Margetts BM, Burney PG. Dietary antioxidants and asthma in adults . population-based case–control study. Am. J. Respir. Crit. Care Med.164, 1823–1828 (2001).
   PubMed Web of Science ®Google Scholar
• Butland BK, Fehily AM, Elwood PC. Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax55, 102–108 (2000).
   PubMed Web of Science ®Google Scholar
• Okoko BJ, Burney PG, Newson RB, Potts JF, Shaheen SO. Childhood asthma and fruit consumption. Eur. Respir. J.29, 1161–1168 (2007).
   Google Scholar
• Garcia V, Arts ICW, Sterne JAC, Thompson RL, Shaheen SO. Dietary intake of flavonoids and asthma in adults. Eur. Respir. J.26, 449–452 (2005).
   PubMed Web of Science ®Google Scholar
• van der Sluis AA, Dekker M, de Jager A, Jongen WM. Activity and concentration of polyphenolic antioxidants in apple: effect of cultivar, harvest year, and storage conditions. J. Agric. Food Chem.49, 3606–3613 (2001).
   PubMed Web of Science ®Google Scholar
• Eberhardt MV, Lee CY, Liu RH. Antioxidant activity of fresh apples. Nature405, 903–904 (2000).
   PubMed Web of Science ®Google Scholar
• Watson L, Margetts B, Howarth P, Dorward M, Thompson R, Little P. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. Eur. Respir. J.20, 313–318 (2002).
   PubMed Web of Science ®Google Scholar
• Tabak C, Arts IC, Smit HA, Heederik D, Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones. The MORGEN Study. Am. J. Respir. Crit. Care Med.164, 61–64 (2001).
   PubMed Web of Science ®Google Scholar
• Walda IC, Tabak C, Smit HA et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur. J. Clin. Nutr.56, 638–643 (2002).
   PubMed Web of Science ®Google Scholar
• Okamoto T. Safety of quercetin for clinical application (review). Int. J. Mol. Med.16, 275–278 (2005).
   PubMed Web of Science ®Google Scholar
• Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? and gone? Clin. Biochem.30, 91–113 (1997).
   PubMed Web of Science ®Google Scholar
• Su HY, Cherng SH, Chen CC, Lee H. Emodin inhibits the mutagenicity and DNA adducts induced by 1-nitropyrene. Mutat. Res.329, 205–212 (1995).
   PubMed Web of Science ®Google Scholar
• Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z, Rosen RT. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J. Agric. Food Chem.48, 253–256 (2000).
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov.5, 493–506 (2006).
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Tsang E, Karumanchiri A, Diamandis E, Soleas G, Ng E. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem.68, 1688–1694 (1996).
   PubMed Web of Science ®Google Scholar
• Renaud S, Gueguen R. The French paradox and wine drinking. Novartis Found. Symp.216, 208–217 (1998).
   PubMedGoogle Scholar
• Belleville J. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition18, 173–177 (2002).
   PubMed Web of Science ®Google Scholar
• Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet339, 1523–1526 (1992).
   PubMed Web of Science ®Google Scholar
• Burr ML. Explaining the French paradox. JR Soc. Health115, 217–219 (1995).
   Google Scholar
• Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am. J. Eno. Vitic.43, 49–52 (1992).
   Web of Science ®Google Scholar
• Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J.17, 1975–1985 (2003).
   PubMed Web of Science ®Google Scholar
• Sun AY, Simonyi A, Sun GY. The “French Paradox” and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med.32, 314–318 (2002).
   PubMed Web of Science ®Google Scholar
• Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κ B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol.164, 6509–6519 (2000).
   PubMed Web of Science ®Google Scholar
• Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-κB-independent mechanism. FASEB J.19, 840–841 (2005).
   PubMed Web of Science ®Google Scholar
• Christie PE, Henderson WR Jr. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin. Allergy Immunol.16, 233–254 (2002).
   PubMedGoogle Scholar
• Bittleman DB, Casale TB. 5-hydroxyeicosatetraenoic acid (HETE)-induced neutrophil transcellular migration is dependent upon enantiomeric structure. Am. J. Respir. Cell. Mol. Biol.12, 260–267 (1995).
   Google Scholar
• Schwenk U, Schroder JM. 5-oxo-eicosanoids are potent eosinophil chemotactic factors. J. Biol. Chem.270, 15029–15036 (1995).
   Google Scholar
• Peters SP, Siegel MI, Kagey-Sobotka A, Lichtenstein LM. lipoxygenase products modulate histamine release in human basophils. Nature292, 455–457 (1981).
   Google Scholar
• Szewczuk LM, Forti L, Stivala LA, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem.279, 22727–22737 (2004).
   PubMed Web of Science ®Google Scholar
• Bertelli AA, Baccalini R, Battaglia E, Falchi M, Ferrero ME. Resveratrol inhibits TNF α-induced endothelial cell activation. Therapie56, 613–616 (2001).
   PubMedGoogle Scholar
• Tao HY, Wu CF, Zhou Y et al. The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes. Cell Mol. Immunol.1, 50–56 (2004).
   Google Scholar
• Rotondo S, Rajtar G, Manarini S et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol.123, 1691–1699 (1998).
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF, Fenwick PS et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax58, 942–946 (2003).
   PubMed Web of Science ®Google Scholar
• Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci.70, 81–96 (2001).
   PubMed Web of Science ®Google Scholar
• Boscolo P, Signore AD, Sabbioni E et al. Effects of resveratrol on lymphocyte proliferation and cytokine release. Ann. Clin. Lab. Sci.33, 226–231 (2003).
   Web of Science ®Google Scholar
• Hsieh TC, Halicka D, Lu X et al. Effects of resveratrol on the G0–G1 transition and cell cycle progression of mitogenically stimulated human lymphocytes. Biochem. Biophys. Res. Comm.297, 1311–1317 (2002).
   PubMedGoogle Scholar
• Leonard SS, Xia C, Jiang BH et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Comm.309, 1017–1026 (2003).
   PubMed Web of Science ®Google Scholar
• Taha R, Olivenstein R, Utsumi T et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.161, 636–640 (2000).
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF, Shah P et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.167, 24–31 (2003).
   PubMed Web of Science ®Google Scholar
• Schunemann HJ, Grant BJ, Freudenheim JL et al. Beverage specific alcohol intake in a population-based study: evidence for a positive association between pulmonary function and wine intake. BMC Pulm. Med.2, 3 (2002).
   Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but vey low bioavaliability of oral resveratrol in humans. Drug Metab. Dispos.32, 1377–1382 (2004).
   PubMed Web of Science ®Google Scholar
• Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res.49, 472–481 (2005).
   PubMed Web of Science ®Google Scholar
• Vitaglione P, Sforza S, Galaverna G et al. Bioavailability of trans-resveratrol from red wine in humans. Mol. Nutr. Food Res.49, 495–504 (2005).
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem.36, 79–87 (2003).
   PubMed Web of Science ®Google Scholar
• Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr.132, 257–260 (2002).
   PubMed Web of Science ®Google Scholar
• Dahl R, Henriksen JM, Harving H. Red wine asthma: a controlled challenge study. J. Allergy Clin. Immunol.78, 1126–1129 (1986).
   PubMed Web of Science ®Google Scholar
• Vally H, Carr A, El-Saleh J, Thompson P. Wine-induced asthma: a placebo-controlled assessment of its pathogenesis. J. Allergy Clin. Immunol.103, 41–46 (1999).
   PubMed Web of Science ®Google Scholar
• Wantke F, Hemmer W, Haglmuller T, Gotz M, Jarisch R. Histamine in wine. Bronchoconstriction after a double-blind placebo-controlled red wine provocation test. Int. Arch. Allergy Immunol.110, 397–400 (1996).
   PubMed Web of Science ®Google Scholar
• de Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica30, 857–866 (2000).
   PubMed Web of Science ®Google Scholar
• de Santi C, Pietrabissa A, Mosca F, Pacifici GM. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica30, 1047–1054 (2000).
   PubMed Web of Science ®Google Scholar
• Yu C, Shin YG, Chow A et al. Human, rat, and mouse metabolism of resveratrol. Pharm. Res.19, 1907–1914 (2002).
   PubMed Web of Science ®Google Scholar
• Perez-Arellano JL, Barrios MN, Martin T, Sanchez ML, Jimenez A, Gonzalez-Buitrago JM. Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease. Respir. Med.90, 159–166 (1996).
   Google Scholar
• Murr C, Schroecksnadel K, Winkler C, Ledochowski M, Fuchs D. Antioxidants may increase the probability of developing allergic diseases and asthma. Med. Hypotheses64, 973–977 (2005).
   PubMed Web of Science ®Google Scholar
• Ahn KS, Kim JH, Oh SR, Ryu SY, Lee HK. Inhibitory activity of stilbenes from medicinal plants on the expression of cell adhesion molecules on THP1 cells. Planta Med.66, 641–644 (2000).
   PubMedGoogle Scholar
• Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg. Med. Chem. Lett.10, 323–327 (2000).
   PubMed Web of Science ®Google Scholar
• Wieder T, Prokop A, Bagci B et al. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia15, 1735–1742 (2001).
   PubMed Web of Science ®Google Scholar